title: Clinical presentation, treatment, and prognosis of periocular and orbital amyloidosis in a university-based referral center.
abstract: OBJECTIVE
  The purpose was to present the demographic data, clinical presentation, and treatment options, and to evaluate prognosis, for periocular and orbital amyloidosis in patients at the Songklanagarind Hospital, Thailand.
  
  
  METHODS
  This was a retrospective study that reviewed the clinical records of six patients who were diagnosed with periocular and orbital amyloidosis between January 1, 2002 and December 31, 2011.
  
  
  RESULTS
  The series included six patients (five female and one male). The mean age was 39.7 years (range 15-79 years). There were five cases of unilateral lesion and one case of bilateral lesion. The most common symptom was a mass lesion (83.3%), followed by irritation (66.7%), bloody tears (16.7%), epiphora (16.7%), eye pain (16.7%), and ptosis (16.7%). Five cases had periocular involvement and one case had orbital involvement. Five cases were investigated to rule out systemic amyloidosis, and no systemic involvement was found in these cases. The median duration of symptoms was 6 months, but the mean was 31 months. The main treatment option was surgical excision. The mean follow-up time was 41 months. There was disease progression in 20% of cases after definitive treatment.
  
  
  CONCLUSIONS
  Periocular and orbital amyloidosis presented with a variety of symptoms, depending on the location of the disease. A mass lesion was the most common symptom. The intent of the treatment modalities was to spare function.
authors: Department of Ophthalmology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand.
authors: Orapan
authors: O
authors: Aryasit
authors: Passorn
authors: P
authors: Preechawai
authors: Kanita
authors: K
authors: Kayasut
keywords: conjunctiva; eyelid; primary localized amyloidosis
references: J Intern Med. 2004 Feb;255(2):159-78
references: 14746554
references: Ophthalmology. 2004 May;111(5):1043-7
references: 15121386
references: Am J Hematol. 2010 Jul;85(7):506-9
references: 20575017
references: J Med Assoc Thai. 1995 Jul;78(7):374-8
references: 7658183
references: Amyloid. 2005 Mar;12(1):1-4
references: 16076605
references: Surv Ophthalmol. 2006 Jul-Aug;51(4):419-33
references: 16818085
references: Annu Rev Med. 2006;57:223-41
references: 16409147
references: Arch Pathol Lab Med. 2010 Apr;134(4):545-51
references: 20367306
references: Amyloid. 2006 Sep;13(3):135-42
references: 17062379
references: Arch Ophthalmol. 2009 May;127(5):645-8
references: 19433714
references: Ophthalmology. 2006 Sep;113(9):1657-64
references: 16828514
references: Eye (Lond). 2001 Oct;15(Pt 5):679-80
references: 11702995
references: Klin Monbl Augenheilkd. 2011 Jun;228(6):555-64
references: 20725885
references: J Dermatol. 2008 Jun;35(6):371-2
references: 18578717
references: Invest Ophthalmol Vis Sci. 2003 Aug;44(8):3278-81
references: 12882770
references: Eye (Lond). 1997;11 ( Pt 3):411-7
references: 9373488
references: Orbit. 2010 Oct;29(5):274-7
references: 20572755
references: Orbit. 2008;27(6):432-7
references: 19085298
references: Curr Opin Rheumatol. 2004 Jan;16(1):67-75
references: 14673392
references: Clin Ophthalmol. 2008 Sep;2(3):685-7
references: 19668776